ELV

Elevance Health, Inc. ·NYSE·Healthcare
399.15 live · 2026-08-12 15:59
53.0%
Brown Bear Score
26.8%
Business Conviction Score
75.0%
Position Health Score
1.4%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +36.5% · range 280.74–426.79

The Businesswhat the company reports

Business & cash flow

FCF / assets 2.6%
OCF / assets 3.5%
FCF / revenue 2.2%
Gross margin 26.0%
ROIC 6.7%
Forward P/E 13.5

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Price has run ahead of forward EPS growth by 8.2pp

Confidence 95.0/100

Takeaway Price has moved further than forward earnings growth currently justifies — worth weighing against the rest of the entry case.

Reported earnings

Next report 2026-10-19 before the open · consensus EPS 4.70

Q3 23 revenue: 42.85bnQ3 23 net income: 1.29bnQ3 23 EPS: 5.45Q4 23 revenue: 42.65bnQ4 23 net income: 856.00mQ4 23 EPS: 3.61Q4 23Q1 24 revenue: 42.58bnQ1 24 net income: 2.25bnQ1 24 EPS: 9.59Q2 24 revenue: 43.89bnQ2 24 net income: 2.30bnQ2 24 EPS: 9.85Q2 24Q3 24 revenue: 45.11bnQ3 24 net income: 1.02bnQ3 24 EPS: 4.36Q4 24 revenue: 45.44bnQ4 24 net income: 418.00mQ4 24 EPS: 1.79Q4 24Q1 25 revenue: 48.89bnQ1 25 net income: 2.18bnQ1 25 EPS: 9.61Q2 25 revenue: 49.78bnQ2 25 net income: 1.74bnQ2 25 EPS: 7.72Q2 25Q3 25 revenue: 50.71bnQ3 25 net income: 1.19bnQ3 25 EPS: 5.32Q4 25 revenue: 49.75bnQ4 25 net income: 547.00mQ4 25 EPS: 2.44Q4 25Q1 26 revenue: 50.18bnQ1 26 net income: 1.76bnQ1 26 EPS: 8.00Q2 26 revenue: 50.47bnQ2 26 net income: 1.46bnQ2 26 EPS: 6.71Q2 26

Revenue Net incomeEPS (GAAP) (1.79–9.85, own scale) Derived Q4

12 quarters to Q2 26. Revenue and net income share one scale, so the gap between them is the margin. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-06-30 50.47bn +1.4% 1.46bn 6.71 7.45 +18.9% 2026-07-15
2026-03-31 50.18bn +2.6% 1.76bn 8.00 12.58 +15.1% 2026-04-22
2025-12-31 (derived) 49.75bn +9.5% 547.00m 2.44 3.33 +6.5% 2026-02-06
2025-09-30 50.71bn +12.4% 1.19bn 5.32 6.03 +21.0% 2025-10-21

Earnings response

Typical move around a filing ±5.7%
On an ordinary two days ±1.3% — filings move it 4.4× as much
Direction 5 up, 7 down over 12 filings
Revenue change and price reaction, by quarter
Q3 22 revenue +11.5% year on yearQ3 22 filed 2022-10-19: price +5.0%Q1 23 revenue +10.7% year on yearQ1 23 filed 2023-04-19: price -5.8%Q1 23Q2 23 revenue +13.0% year on yearQ2 23 filed 2023-07-19: price +7.2%Q3 23 revenue +7.3% year on yearQ3 23 filed 2023-10-18: price -0.5%Q3 23Q1 24 revenue +1.0% year on yearQ1 24 filed 2024-04-18: price +4.4%Q2 24 revenue +0.5% year on yearQ2 24 filed 2024-07-17: price -8.8%Q2 24Q3 24 revenue +5.3% year on yearQ3 24 filed 2024-10-17: price -13.3%Q1 25 revenue +14.8% year on yearQ1 25 filed 2025-04-22: price +5.0%Q1 25Q2 25 revenue +13.4% year on yearQ2 25 filed 2025-07-17: price -19.6%Q3 25 revenue +12.4% year on yearQ3 25 filed 2025-10-21: price -2.5%Q3 25Q1 26 revenue +2.6% year on yearQ1 26 filed 2026-04-22: price +5.5%Q2 26 revenue +1.4% year on yearQ2 26 filed 2026-07-15: price -12.6%Q2 26

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-06-30 2026-07-15 +1.4% -12.6%
2026-03-31 2026-04-22 +2.6% +5.5% +7.7%
2025-09-30 2025-10-21 +12.4% -2.5% -7.6%
2025-06-30 2025-07-17 +13.4% -19.6% +9.2%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Shrinking — shares retired
Diluted shares 217.9M as at 2026-06-30
Change over 1 year -3.5%
Change over 3 years -8.4%
Public float $87.35bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyAt Support Zone
Reference band 381.13 — 392.68
Protective stop 359.44 (Atr, 7.1% risk)
Support 384.98 (5 touches, 3.7% away)
Resistance 399.92 (0.2% away)

Takeaway The shares are nearer the ceiling than the floor: about 0.2% below 399.92, where sellers have turned up before, and 3.7% above 384.98, where buyers have stepped in before. That floor has held 5 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 7.1% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice INSIDE the cloud | periods 7/21/41 (80% of classic 9/26/52)
LinesTenkan/Kijun BEAR | cloud twist BEAR
Cloud thickness26% percentile (thin — little structure to fight through)
Chikou spanNot clear of price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading inside its cloud — a shaded band drawn from several of its own moving averages, currently 393.55 to 399.61. Inside the band those averages disagree with each other, so the indicator is not saying much either way. Its shorter-term averages agree with that.

Trailing returns

21 days -6.5%
63 days +1.5%
126 days +22.6%
252 days +37.3%
Below 252d high6.5%

Trend context

PositionAt trend
ExtensionNormal
Trend slopeFlat
Direction of travelHolding its deviation

Takeaway The share price is close to the level its own longer-run trend suggests is fair, and that fair level is going sideways. The gap between the two has been fairly steady. Neither is stretched far enough to stand out.

Volatility

State In a squeeze
Current band width8.8% of price
Recent tightest8.2% (1 sessions ago, narrower than 94.0% of its history)
Expansion since1.08×
Band 367.37 — 401.11

Takeaway Lately this share price has been swinging around inside a range roughly 9% wide, and it recently went unusually quiet — calmer than it has been 94% of the time. When a stock goes quiet like this, its next move tends to look big by comparison. But quiet says nothing about which way it will go: Brown Bear tested calm-before-a-move as a reason to buy, and it did not work.

Historical trends

0255075100Share price 372.85–426.792026-07-032026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Below its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway The heaviest trading has been happening on days when the price falls: when large numbers of shares change hands, the price has tended to go down rather than up. That tells you where the weight of trading has been. It does not tell you what happens next, and it is not a signal to sell.

Options Positioning

No binary-event flag

ELV: no binary-event flag. Near IV 32%, far IV 32% (ratio 1.02), implied move 4.0%.

Implied volatility 32% near (9d) · 32% far (65d)
Term structure 1.02× near/far
Historical volatility 32%
Implied vs historical 0.99×
Implied move ±4.0% by 2026-08-21
Implied move vs ATR 0.49×
Skew Flat (1.01×)
Call wall 430.00 (+7.7% away)
Put wall 360.00 (-9.8% away)
Gamma pin 390.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 4.0% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Mixed Rotation Phase

Rotation health 78.8/100; Strong Rotation Tailwind.

Rotation health 78.8
Rotation strength 82.9
LegQuadrantRS-RatioRS-Mom
Stock vs sector Leading 101.6 115.9
Stock vs SPY Improving 95.4 114.7
Sector vs SPY Improving 86.4 102.1

Direction of travel: North-East / strengthening leadership

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Altman Z-score 2.96 (+2.0)
  • Insider conviction score (+13.0)
  • Gross margin quality: 26.0% (+0.6)
  • ROIC quality: 6.7% (+0.5)
  • FCF margin quality: 2.2% (+0.6)
  • FCF margin improving by -1.1 pts (+-1.0)
  • High earnings quality (accrual ratio 0.011) (+1.0)
  • Track 2: MACD histogram state (2.22) (+12.0)
  • Track 2: MACD line/signal trend quality (+18.0)
  • Track 2: MACD slope expanding (+8.0)
  • Track 2: 20-day momentum acceleration 0.05 (+4.0)
  • Track 2: ADX 24.7 and flat (+5.0)
  • Track 2: relative momentum rank 0.75 (+8.3)
  • Track 2: Bullish MACD divergence (+4.0)
  • Track 2: price above EMA20 by 2.3% (+1.9)
  • Track 2: EMA20 slope expanding 0.8% (+2.1)
  • Track 2: MACD histogram acceleration 2.23 (+12.0)
  • Track 2: RSI trend quality 64.6, 5-day change +3.1 (+2.5)
  • Track 2: price above EMA50 by 2.7% (+2.2)
  • Track 2: constructive pullback within uptrend (+10)
  • Track 2: Bollinger position 0.94 (+7.5)
  • Regime convergence: SUPPORT_RESISTANCE_BOUNCE confidence 72.9/100 (EMERGING) (+14.6)

Negative signals

  • Track 2: negative MACD regime (-8.0)
  • Track 2: weak volume for momentum setup (0.59x average)
  • Track 2: bearish DI spread (-2.6)
  • Track 2: weak VPT confirmation (-0.00)
  • Gross margin improving by -74.0 pts (+-1.0)
  • ROIC improving by -1.1 pts (+-2.0)
  • Track 2 structural exemption: structural score 13.7/100 below the 25 quality floor; this is an unowned speculative candidate, so the universal SELL gate was skipped and the Track 2 momentum/RRG grid was allowed to evaluate instead. Structural quality here is weak by design for this kind of candidate -- treat any resulting BUY as higher risk than a Track 1 signal.

Chase risk is not elevated for this name, so extension penalties are omitted from the negative signals above.